Stephen Lim

826 total citations
50 papers, 558 citations indexed

About

Stephen Lim is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Stephen Lim has authored 50 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 18 papers in Oncology and 17 papers in Genetics. Recurrent topics in Stephen Lim's work include Multiple Myeloma Research and Treatments (19 papers), CAR-T cell therapy research (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers). Stephen Lim is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), CAR-T cell therapy research (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers). Stephen Lim collaborates with scholars based in United States, Switzerland and India. Stephen Lim's co-authors include Anthony P. Heaney, Hrayr K. Shahinian, William H. Yong, Rakesh Awasthi, Jie Zhang, Harald J. Maier, John D. Carmichael, Anat Ben-Shlomo, Galen Cook‐Wiens and Vivien Bonert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stephen Lim

48 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Lim United States 11 195 187 172 142 129 50 558
Livia Hegerova United States 8 76 0.4× 67 0.4× 140 0.8× 93 0.7× 181 1.4× 20 500
Jessica Quarna Italy 12 21 0.1× 101 0.5× 256 1.5× 257 1.8× 115 0.9× 17 577
Vivian Weiß United States 17 194 1.0× 29 0.2× 305 1.8× 188 1.3× 14 0.1× 55 714
Mufaddal Moonim United Kingdom 10 34 0.2× 45 0.2× 94 0.5× 38 0.3× 55 0.4× 37 376
Carlo Alberto Giorgi Italy 12 34 0.2× 87 0.5× 280 1.6× 51 0.4× 24 0.2× 35 513
Sylvie Daliphard France 12 15 0.1× 160 0.9× 97 0.6× 88 0.6× 197 1.5× 27 489
Tomohiro Fujii Japan 19 95 0.5× 13 0.1× 261 1.5× 216 1.5× 53 0.4× 47 887
Naoki Kurita Japan 12 20 0.1× 74 0.4× 91 0.5× 93 0.7× 110 0.9× 60 471
Jan Willems Sweden 11 46 0.2× 32 0.2× 192 1.1× 75 0.5× 42 0.3× 16 545
Alexandre Kaliski France 10 97 0.5× 67 0.4× 96 0.6× 70 0.5× 16 0.1× 13 379

Countries citing papers authored by Stephen Lim

Since Specialization
Citations

This map shows the geographic impact of Stephen Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Lim more than expected).

Fields of papers citing papers by Stephen Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Lim. The network helps show where Stephen Lim may publish in the future.

Co-authorship network of co-authors of Stephen Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Lim. A scholar is included among the top collaborators of Stephen Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Lim. Stephen Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landsburg, Daniel J., Matthew J. Frigault, S.R. Foley, et al.. (2025). Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry. Journal for ImmunoTherapy of Cancer. 13(2). e009890–e009890. 3 indexed citations
2.
Zhong, Xiang, et al.. (2025). Nurse‐Led Apheresis Service in a Pediatric Restructured Hospital: The Past, the Present, and the Future. Journal of Clinical Apheresis. 40(1). e70009–e70009. 1 indexed citations
3.
Landsburg, Daniel J., Richard T. Maziarz, Amy Moskop, et al.. (2024). Efficacy and Safety of Tisagenlecleucel in Patients with Relapsed/Refractory Follicular Lymphoma: A Real-World Analysis from the Center for Blood and Marrow Transplant Research (CIBMTR) Registry. Blood. 144(Supplement 1). 4398–4398. 1 indexed citations
4.
Berenson, James R., Stephanie R. Rice, Ralph V. Boccia, et al.. (2023). A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone. Blood. 142(Supplement 1). 4753–4753. 1 indexed citations
5.
Landsburg, Daniel J., Amy Moskop, S.R. Foley, et al.. (2023). Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting. Blood. 142(Supplement 1). 3496–3496. 2 indexed citations
6.
7.
8.
Berenson, James R., Tanya M. Spektor, Regina A. Swift, et al.. (2020). A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research. 26(10). 2346–2353. 25 indexed citations
9.
Bharadwaj, Parag, et al.. (2020). Aligning Palliative Care with Cure: Experience of Integrating with Hematopoietic Stem Cell Transplant. Journal of Palliative Medicine. 23(2). 162–163. 1 indexed citations
10.
Fowler, Nathan, Guifang Chen, Stephen Lim, et al.. (2020). reatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma. Journal of health economics and outcomes research. 7(2). 148–157. 9 indexed citations
11.
Lim, Stephen, et al.. (2014). Alopecia areata as a paraneoplastic syndrome of Hodgkin’s lymphoma: A case report. Molecular and Clinical Oncology. 2(4). 596–598. 10 indexed citations
12.
Ong, Frank S, Kingshuk Das, Wendell-Lamar B. Blackwell, et al.. (2012). Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing. Expert Review of Molecular Diagnostics. 12(6). 593–602. 59 indexed citations
13.
Steinberg, Amir, et al.. (2011). Precursor T-Cell Acute Lymphoblastic Leukemia/Lymphoma with Rare Presentation in the Urinary Bladder. SHILAP Revista de lepidopterología. 3(2). e18–e18. 2 indexed citations
14.
Koppel, Ahrin, et al.. (2007). Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria. Transfusion. 47(10). 1902–1904. 27 indexed citations
15.
Lim, Stephen, et al.. (2006). Temozolomide: a novel treatment for pituitary carcinoma. The Lancet Oncology. 7(6). 518–520. 135 indexed citations
16.
Zelivianski, Stanislav, et al.. (2002). Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter. Oncogene. 21(23). 3696–3705. 12 indexed citations
17.
18.
19.
Lim, Stephen, et al.. (1996). Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia. Cancer Genetics and Cytogenetics. 86(2). 165–167. 1 indexed citations
20.
Lim, Stephen, et al.. (1996). Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation. Leukemia & lymphoma. 20(5-6). 453–456. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Livia Hegerova Breakdown of academic impact, for papers by Jessica Quarna Breakdown of academic impact, for papers by Vivian Weiß Breakdown of academic impact, for papers by Mufaddal Moonim Breakdown of academic impact, for papers by Carlo Alberto Giorgi Breakdown of academic impact, for papers by Sylvie Daliphard Breakdown of academic impact, for papers by Tomohiro Fujii Breakdown of academic impact, for papers by Naoki Kurita Breakdown of academic impact, for papers by Jan Willems Breakdown of academic impact, for papers by Alexandre Kaliski
Rankless by CCL
2026